Skip to content
lifestyle.forkstofeet.com
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
ABLi Therapeutics
ABLi Therapeutics Announces Outcomes from its Parkinson’s-related Biomarker Study Demonstrating Modification of Human Disease with Risvodetinib
August 4, 2026
ABLi Therapeutics Appoints Industry Veteran Dr. Rachelle S. Doody to its Board of Directors
May 6, 2026